Neuromodulation for Spinal Cord Injury
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new treatment using electromagnetic signals (electromagnetic neuromodulation) to help people with spinal cord injuries improve bladder function. Researchers will divide participants into groups to assess the treatment's effectiveness for those who have undergone motor training and those who have not. Men aged 18-45 who have had a spinal cord injury for at least a year and require catheter use may qualify if they can attend sessions twice a week for six months. As an unphased trial, this study offers participants the chance to contribute to groundbreaking research that could enhance quality of life for many.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this neuromodulation technique is safe for improving urinary bladder function in spinal cord injury patients?
Research has shown that treatments involving spinal cord neuromodulation, such as electromagnetic methods, have been safe in past studies. For instance, one study found that non-invasive electrical stimulation of the spinal cord improved arm and hand functions in individuals with neck spinal cord injuries, without major side effects.
Additionally, reviews of spinal cord stimulation techniques generally support their safe use in patients. This suggests that neuromodulation is usually well-tolerated and safe. However, individual experiences can vary, so discussing any concerns with a healthcare provider is always advisable.12345Why are researchers excited about this trial?
Researchers are excited about electromagnetic neuromodulation for spinal cord injury because it offers a novel approach to enhancing motor function. Unlike traditional therapies, which often rely on physical rehabilitation and surgery, this treatment uses electromagnetic waves to stimulate nerve activity. This method holds promise for reactivating neural pathways that are otherwise dormant, potentially offering improved outcomes for individuals with spinal cord injuries. The excitement also stems from its non-invasive nature, which could lead to fewer complications and a quicker recovery compared to more invasive procedures.
What evidence suggests that electromagnetic neuromodulation is effective for improving urinary bladder function in spinal cord injury?
Research has shown that electromagnetic techniques to stimulate nerves can help people with spinal cord injuries (SCI) improve their abilities. In this trial, participants will be divided into different arms to evaluate the effects of neuromodulation. One study examined new spinal cord stimulation methods and found they could aid recovery without causing serious side effects. Another study focused on ARC EX Therapy, which improved hand and arm movement in people with neck-related SCI. Early tests of magnetic field therapy (MFT) also showed promising results for SCI recovery. These findings suggest that nerve stimulation could help people with SCI regain some lost functions, such as bladder control.13467
Are You a Good Fit for This Trial?
This trial is for males aged 18-45 with spinal cord injury (SCI) at least one year post-injury, who have complete motor SCI (ASIA A or B), and need catheterization for bladder control. Participants must be able to attend sessions twice a week for six months, have non-progressive SCI between C2-T8, and use their lower extremities for standing/stepping assistance.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive spinal cord neuromodulation through transcutaneous electrical stimulation and/or magnetic stimulation
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Electromagnetic Neuromodulation
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, Los Angeles
Lead Sponsor